Nature Reviews Drug Discovery - Johnson & Johnson has discontinued development of aticaprant for depression with anhedonia, a blow to hopes for drugs for ‘domains’ of psychiatric disorders.

According to a recent study by Carrier, manufacturers of brand-name drugs were responsible for 108 of 124 citizens petitions -- or 92 percent -- filed with the FDA between 2011 and 2015.

President Donald Trump has threatened tariffs on drugs coming from overseas, but it might take more than that to reroute the ...

The U.S. should not impose price controls, but if it does, drug pricing decisions should not be outsourced to the EU, UK, or Canada. Adopting the MFN will also harm innovation.

South Austin homeless camp drawing concerns as drug use, open fires continue by: Nabil Remadna. Posted: Mar 7, 2025 / 05:48 PM CST. Updated: Mar 8, 2025 / 03:29 PM CST.